Joseph A. Morrone

IBM (United States)

Papers

1

Total Citations

2

H-Index

1

About

Joseph A. Morrone is a leading computational chemist whose research bridges the frontiers of structure-based drug discovery and fragment-based design. His work centers on developing innovative computational methodologies to explore chemical space and optimize protein-ligand interactions. Morrone’s most notable contribution is the creation of Syndirella, a synthesis-directed fragment elaboration platform that enables systematic exploration of binding sites beyond traditional catalog compounds. This tool represents a paradigm shift in how researchers leverage fragment screening data, allowing for the rapid generation of diverse, synthetically accessible derivatives that maximize interaction sampling. By integrating synthetic feasibility directly into the design process, Syndirella addresses a critical bottleneck in early-stage drug discovery, helping to avoid premature convergence on suboptimal chemical series. Though a relatively recent publication, this work has already garnered attention for its practical impact on medicinal chemistry workflows. Morrone’s broader research portfolio encompasses computational methods for molecular recognition, free energy calculations, and the development of open-source tools that democratize access to advanced drug design capabilities. His contributions are shaping how the pharmaceutical industry approaches fragment-to-lead optimization, making him a rising voice in computational drug discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Syndirella: Synthesis-directed fragment elaboration enables extensive binding site exploration beyond catalog compounds
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: IBM (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago